Cytosorbents Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CTSO research report →
About the company
Cytosorbents Corporation specializes in creating and bringing to market innovative medical devices. Their core expertise lies in a unique blood purification platform, built upon a proprietary adsorbent and porous polymer technology. The company's leading product, CytoSorb, is an extracorporeal filter designed to remove cytokines from the blood.
- CEO
- Phillip Chan
- IPO
- 2006
- Employees
- 149
- HQ
- Princeton, NJ, US
Price Chart
- Market Cap
- $24.51M
- P/E
- -2.09
- P/S
- 0.66
- P/B
- 11.15
- EV/EBITDA
- -4.97
- Div Yield
- 0.00%
- Gross Margin
- 71.01%
- Op Margin
- -36.01%
- Net Margin
- -31.85%
- ROE
- -165.13%
- ROIC
- -41.17%
- Revenue
- $37.06M · 4.12%
- Net Income
- $-8,198,000 · 60.43%
- EPS
- $-0.13 · 65.79%
- Op Income
- $-14,239,000
- FCF YoY
- 14.76%
- 52W High
- $1.22
- 52W Low
- $0.35
- 50D MA
- $0.50
- 200D MA
- $0.67
- Beta
- 1.36
- Avg Volume
- 156.65K
Get TickerSpark's AI analysis on CTSO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 15, 26 | MARIANI PETER J | buy | 100,000 |
| Jun 15, 26 | Chan Phillip P. | buy | 10,333 |
| Jun 12, 26 | Chan Phillip P. | buy | 251,136 |
| Nov 18, 25 | Chan Phillip P. | other | 100,000 |
| Aug 8, 25 | Chan Phillip P. | other | 105,600 |
| Aug 8, 25 | Chan Phillip P. | other | 136,400 |
| Aug 8, 25 | Jones Edward Raymond | other | 22,000 |
| Aug 8, 25 | BATOR MICHAEL G. | other | 44,000 |
| Aug 8, 25 | MARIANI PETER J | other | 71,500 |
| Aug 8, 25 | MARIANI PETER J | other | 90,000 |
Our CTSO coverage
Recent articles, reports, and earnings notes.
No research on CTSO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CTSO report →Similar companies
Peers in the same neighborhood.